Hold For Now: Shattuck Labs’ SL-172154 Potential In Early Trials (NASDAQ:STTK)Hold For Now: Shattuck Labs’ SL-172154 Potential In Early Trials (NASDAQ:STTK)
jarun011Shattuck Labs, Inc. (NASDAQ:STTK) developed a proprietary Agonist Redirected Checkpoint [ARC] platform to create bi-functional fusion proteins to treat cancer[...]